Subclinical atherosclerosis in patients with mild SLE appears to progress similarly to that in the general population, underlining the importance of managing cardiovascular risk factors, researchers say.

The reassuring findings from a small, longitudinal study suggest it’s possible to monitor and implement preventive strategies to temper the excess risk that leads to cardiovascular events being the main cause of death among patients with lupus, they say.